Sage Bionetworks

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Sage Bionetworks sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).

2 total trials 1 currently recruiting upper half by trial count

Sage Bionetworks: 2 sponsored US clinical trials, 1 recruiting.

Sage Bionetworks sponsors 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Basal Ganglia Diseases, with 1 trials.

Mid-pack sponsor footprint

Sage Bionetworks is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

2 total, page 1 of 1

RECRUITING

Psorcast Mobile Study

NCT05621369
ACTIVE NOT RECRUITING NA

Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)

NCT02696603

Therapeutic Areas

Basal Ganglia Diseases 1
Dactylitis 1
Psoriatic Nail 1
Psoriatic Conditions 1
Neurodegenerative Diseases 1
Parkinsonian Disorders 1
Joint Pain 1
Brain Diseases 1
Plaque Psoriasis 1
Dermatologic Disease 1

What is open in the Sage Bionetworks pipeline

1 recruiting of 2 indexed (50% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Basal Ganglia Diseases (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Sage Bionetworks: open-pipeline peers nationwide

Peers matched on 2 registered trials and 50% open enrollment, not the therapeutic-area sidebar.

Sage Bionetworks sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1.522.533.544.5 0%20%40%60% Total trials Recruiting share Sage Bionetworks1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO Health3ive Labs60 Degrees Pharmaceuticals7 Hills PharmaAbcentra
Sage Bionetworks sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Sage Bionetworks sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 2 trials (± recruiting share)

Sponsors near 50% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Sage Bionetworks page

2 registered trials is a research-attention snapshot, not an endorsement of Sage Bionetworks or any single study.

  • 1 of Sage Bionetworks's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Basal Ganglia Diseases is the condition Sage Bionetworks studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Basal Ganglia Diseases trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Sage Bionetworks pipeline card: 2 registered trials from official public datasets.Report a data error.